Longterm Effectiveness of Artificial Intelligence-assisted Colonoscopy on Adenoma Recurrence

ConditionScreening Colonscopy

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorChinese University of Hong Kong

About this trial

We hypothesize that AI-assisted colonoscopy can reduce post-colonoscopy neoplasia incidence after 3 years, over standard colonoscopy. Moreover, this protective effect may allow surveillance intervals to be lengthened, by modifying long-term outcome of high-risk subgroup.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

ENDO-AID CADe

Treatment groups

775 Participants

are divided into 1 treatment group

Sponsors and collaborators

Chinese University of Hong Kong

Lead sponsor

Source ClinicalTrials.gov